BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33717091)

  • 1. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
    Kasamatsu T; Awata M; Ishihara R; Murakami Y; Gotoh N; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Saitoh T; Murakami H
    Clin Exp Med; 2020 Feb; 20(1):51-62. PubMed ID: 31620907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
    Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
    Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
    Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.
    Liu CP; Jiang JA; Wang T; Liu XM; Gao L; Zhu RR; Shen Y; Wu M; Xu T; Zhang XG
    Genet Mol Res; 2013 Apr; 12(2):1373-82. PubMed ID: 23661460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients.
    Thude H; Schipler AD; Treszl A; Peine S; Koch M; Sterneck M; Nashan B
    Hum Immunol; 2013 Aug; 74(8):1041-5. PubMed ID: 23628397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients.
    Guo Y; Gao J; Gao S; Shang M; Guo F
    Oncotarget; 2016 Apr; 7(17):23088-95. PubMed ID: 27081086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
    Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
    BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.
    Ali ESG; Bassyouni RH; Abdelaleem OO; Hassan EA; Gaber SN
    Virus Res; 2022 Mar; 310():198684. PubMed ID: 35063794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.
    Cai GM; Gao Z; Yue YX; Xie YC; Gao X; Hao HJ; Zhang XJ; Wang Q; Liang B; Li HF
    J Clin Neurosci; 2019 Nov; 69():31-37. PubMed ID: 31473094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.
    Sun L; Meng Y; Xie Y; Zhang H; Zhang Z; Wang X; Jiang B; Li W; Li Y; Yang Z
    PLoS One; 2014; 9(7):e101986. PubMed ID: 25003519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
    Li F; Yuan W; Wu X
    Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.
    Liu J; Tang W; Lin W; Wang Y; Chen Y; Wang J; Liu M; Xu W; Lin J; Zhang L
    DNA Cell Biol; 2019 May; 38(5):443-448. PubMed ID: 30888206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Yang MM; Sun HY; Meng T; Qiu SH; Zeng QQ; Ng TK; Jiang L; Deng TM; Zeng AN; Wang J; Luo XL
    Front Immunol; 2021; 12():608723. PubMed ID: 33643312
    [No Abstract]   [Full Text] [Related]  

  • 20. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.